Date published: 2026-4-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

LGI4 Inhibitors

LGI4 is a pivotal protein implicated in the development and function of the nervous system. Functioning primarily at the juncture of neural cells, LGI4 facilitates key processes that are essential for the proper communication between neurons. It is most notably recognized for its role in the formation of myelin, the insulating layer that enhances the speed and efficiency of electrical signal transmission along neural pathways. The expression of LGI4 is a tightly regulated process within the body, responding to a complex interplay of genetic and environmental signals. Aberrations in the expression of LGI4 have been linked to a spectrum of neural developmental disorders, highlighting the importance of understanding the mechanisms that govern its activity.

In the realm of biochemical research, a variety of chemical compounds have been identified that can potentially inhibit the expression of LGI4. These inhibitors operate through diverse mechanisms, each interacting with different molecular pathways to exert their influence on LGI4 expression levels. For instance, histone deacetylase inhibitors, such as Trichostatin A and Vorinostat, could potentially repress LGI4 expression by altering the conformation of chromatin, thereby restricting the access of transcriptional machinery to the LGI4 gene. Similarly, DNA methyltransferase inhibitors like 5-Azacytidine may lead to the hypomethylation of gene promoter regions, resulting in the suppression of LGI4 transcription. On another front, compounds that modulate signaling pathways, such as the PI3K inhibitor LY294002, could diminish LGI4 expression by interfering with downstream transcriptional processes. Moreover, inhibitors of receptor tyrosine kinases, exemplified by Sunitinib and Gefitinib, may also downregulate LGI4 by disrupting upstream signaling cascades that are integral for the initiation of LGI4 gene expression. Each of these chemicals, while not exclusively targeting LGI4, presents a unique approach to understanding the regulation of LGI4 at a molecular level. The study of these inhibitors provides valuable insight into the cellular mechanisms that control neural development and maintenance, expanding the breadth of knowledge in molecular neurobiology.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A may downregulate LGI4 expression by acetylating histones, thereby altering the accessibility of the gene's promoter region to transcriptional machinery.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By incorporating into DNA and RNA, 5-Azacytidine could decrease LGI4 expression through the hypomethylation of gene promoter regions, which would suppress transcription initiation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin might inhibit LGI4 synthesis by blocking mTOR activity, which is crucial for initiating cap-dependent translation, including the translation of mRNAs coding for LGI4.

XAV939

284028-89-3sc-296704
sc-296704A
sc-296704B
1 mg
5 mg
50 mg
$36.00
$117.00
$525.00
26
(1)

XAV939 could reduce the expression of LGI4 by stabilizing axin and promoting beta-catenin degradation, subsequently decreasing Wnt signaling and its transcriptional activation of LGI4.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid could suppress LGI4 expression by binding to its receptors and altering the transcription of genes involved in the differentiation processes that include LGI4.

Spironolactone

52-01-7sc-204294
50 mg
$109.00
3
(1)

Spironolactone might decrease LGI4 expression by antagonizing aldosterone receptors, leading to changes in mineralocorticoid-responsive gene transcription.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$78.00
$260.00
18
(1)

Hydroxyurea could reduce the expression of LGI4 by inhibiting DNA synthesis, leading to a general decrease in the transcriptional activity of various genes.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Sunitinib may downregulate LGI4 expression by inhibiting multiple receptor tyrosine kinases and disrupting signal transduction pathways that promote LGI4 transcription.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Gefitinib could inhibit LGI4 expression by blocking EGFR tyrosine kinase activity, which is often upstream of the signaling cascades controlling gene expression.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002 might decrease LGI4 expression by inhibiting PI3K, leading to a reduction in AKT phosphorylation and a consequent fall in transcriptional activities that include LGI4.